D. Keber

856 total citations
42 papers, 675 citations indexed

About

D. Keber is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Epidemiology. According to data from OpenAlex, D. Keber has authored 42 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Hematology and 11 papers in Epidemiology. Recurrent topics in D. Keber's work include Blood properties and coagulation (16 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). D. Keber is often cited by papers focused on Blood properties and coagulation (16 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). D. Keber collaborates with scholars based in Slovenia, Austria and United States. D. Keber's co-authors include Irena Keber, Mišo Šabović, Mojca Stegnar, Aleš Blinc, H.R. Lijnen, G. Lahajnar, Franci Demšar, D Collen, Aleksander Zidanšek and Désiré Collen and has published in prestigious journals such as Biophysical Journal, Heart and Thrombosis and Haemostasis.

In The Last Decade

D. Keber

42 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Keber Slovenia 15 286 181 179 161 148 42 675
Tomiyoshi Saito Japan 13 157 0.5× 174 1.0× 437 2.4× 118 0.7× 39 0.3× 34 718
Séan Murphy Ireland 17 298 1.0× 83 0.5× 222 1.2× 75 0.5× 413 2.8× 52 955
Vijender R. Vaidyula United States 10 134 0.5× 146 0.8× 191 1.1× 81 0.5× 144 1.0× 12 554
Rafael F. Sequeira United States 15 175 0.6× 45 0.2× 736 4.1× 139 0.9× 118 0.8× 33 1.1k
Mirella Gouverneur Netherlands 6 141 0.5× 45 0.2× 106 0.6× 28 0.2× 127 0.9× 7 822
Marcel Scheinman United States 13 140 0.5× 34 0.2× 182 1.0× 198 1.2× 26 0.2× 17 507
Domenico De Lucia Italy 12 89 0.3× 246 1.4× 114 0.6× 138 0.9× 44 0.3× 21 452
B.R. Jaeger Germany 16 94 0.3× 107 0.6× 308 1.7× 15 0.1× 44 0.3× 36 806
W Schoop Germany 12 295 1.0× 21 0.1× 96 0.5× 95 0.6× 68 0.5× 85 599
Marzenna Zielińska Poland 16 63 0.2× 29 0.2× 282 1.6× 23 0.1× 66 0.4× 75 737

Countries citing papers authored by D. Keber

Since Specialization
Citations

This map shows the geographic impact of D. Keber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Keber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Keber more than expected).

Fields of papers citing papers by D. Keber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Keber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Keber. The network helps show where D. Keber may publish in the future.

Co-authorship network of co-authors of D. Keber

This figure shows the co-authorship network connecting the top 25 collaborators of D. Keber. A scholar is included among the top collaborators of D. Keber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Keber. D. Keber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fras, Zlatko, D. Keber, & Wayne L. Chandler. (2004). The effect of submaximal exercise on fibrinolysis. Blood Coagulation & Fibrinolysis. 15(3). 227–234. 7 indexed citations
2.
Blinc, Aleš, et al.. (2002). In vivo release of tissue-type plasminogen activator antigen from the human brachial artery. Thrombosis Research. 106(4-5). 249–255. 3 indexed citations
3.
Maat, Moniek P.M. de, G. Dooijewaard, Piet Meijer, et al.. (2001). Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study*. Blood Coagulation & Fibrinolysis. 12(6). 453–458. 2 indexed citations
4.
Vrtovec, Bojan, et al.. (1999). Carotid intima-media thickness of young coronary patients. Coronary Artery Disease. 10(6). 407–412. 14 indexed citations
5.
Zidanšek, Aleksander, Aleš Blinc, G. Lahajnar, D. Keber, & R. Blinc. (1995). Finger-like lysing patterns of blood clots. Biophysical Journal. 69(3). 803–809. 24 indexed citations
6.
Zidanšek, Aleksander, Aleš Blinc, G. Lahajnar, D. Keber, & R. Blinc. (1993). Lysing patterns of blood clots: a nuclear magnetic resonance imaging study in vitro and mathematical modelling of the lysing pattern kinetics. Journal of Molecular Structure. 294. 283–285. 4 indexed citations
7.
Keber, Irena & D. Keber. (1992). Increased Plasminogen Activator Inhibitor Activity in Survivors of Myocardial Infarction Is Associated with Metabolic Risk Factors of Atherosclerosis. Pathophysiology of Haemostasis and Thrombosis. 22(4). 187–194. 20 indexed citations
8.
Blinc, Aleš, D. Keber, G. Lahajnar, et al.. (1992). Lysing Patterns of Retracted Blood Clots with Diffusion or Bulk Flow Transport of Plasma with Urokinase into Clots – a Magnetic Resonance Imaging Study In Vitro. Thrombosis and Haemostasis. 68(6). 667–671. 44 indexed citations
9.
Keber, D., Matija Cevc, & Irena Keber. (1992). Increased PAI-1 antigen after short term treatment with gemfibrozil as opposed to unchanged levels after bezafibrate and lovastatin. Thrombosis Research. 65. S64–S64. 1 indexed citations
10.
Blinc, Aleš, et al.. (1992). Magnetic Resonance Imaging of Retracted and Nonretracted Blood Clots during Fibrinolysis in vitro. Pathophysiology of Haemostasis and Thrombosis. 22(4). 195–201. 30 indexed citations
11.
Stegnar, Mojca, Polona Peternel, D. Keber, & Nina Vene. (1991). Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis. Thrombosis Research. 64(4). 445–453. 15 indexed citations
12.
Šabović, Mišo, H.R. Lijnen, D. Keber, & Désiré Collen. (1990). Correlation between Progressive Adsorption of Plasminogen to Blood Clots and Their Sensitivity to Lysis. Thrombosis and Haemostasis. 64(3). 450–454. 51 indexed citations
13.
Peternel, Polona, et al.. (1990). Shift work and circadian rhythm of blood fibrinolytic parameters. Fibrinolysis and Proteolysis. 4. 113–115. 14 indexed citations
14.
Keber, D., Zlatko Fras, & Mojca Stegnar. (1988). 97 Separate and joint effect of physical activity and DDAVP infusion on the release of tissue plasminogen activator. Fibrinolysis and Proteolysis. 2. 44–44. 3 indexed citations
15.
Keber, Irena, et al.. (1987). Aspirin decreases fibrinolytic potential during venous occlusion, but not during acute physical activity. Thrombosis Research. 46(2). 205–212. 8 indexed citations
16.
Keber, Irena, et al.. (1987). PHYSICAL ACTIVITY RELEASES TISSUE PLASMINOGEN ACTIVATOR FROM EXERCISING PARTS OF BODY. Thrombosis and Haemostasis. 2 indexed citations
17.
Keber, D., Mojca Stegnar, Nina Vene, Polona Peternel, & Irena Keber. (1986). Diurnal fluctuation of tissue plasminogen activator: Effects of recumbency and parenteral nutrition. Thrombosis Research. 41. 109–109. 2 indexed citations
18.
Keber, Irena & D. Keber. (1985). No significant effect of chronic aspirin use on fibrinolytic response to venous occlusion in coronary patients. Thrombosis Research. 39(6). 761–765. 8 indexed citations
19.
20.
Keber, Irena, et al.. (1979). The influence of combined treatment with propranolol and acetylsalicylic acid on platelet aggregation in coronary heart disease.. British Journal of Clinical Pharmacology. 7(3). 287–291. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomiyoshi Saito Breakdown of academic impact, for papers by Séan Murphy Breakdown of academic impact, for papers by Vijender R. Vaidyula Breakdown of academic impact, for papers by Rafael F. Sequeira Breakdown of academic impact, for papers by Mirella Gouverneur Breakdown of academic impact, for papers by Marcel Scheinman Breakdown of academic impact, for papers by Domenico De Lucia Breakdown of academic impact, for papers by B.R. Jaeger Breakdown of academic impact, for papers by W Schoop Breakdown of academic impact, for papers by Marzenna Zielińska
Rankless by CCL
2026